Cerebrolysin Peptide Fraction
Also known as: CNTF-derived fragments, NAP/Davunetide relationship
Overview
Individual peptide fractions within Cerebrolysin preparation include components that mimic BDNF, GDNF, NGF, and CNTF activity. Research has identified specific small peptide sequences within the preparation responsible for distinct neuroprotective activities, including fragments that activate neurotrophic factor receptors TrkA, TrkB, and GFRα1-4. Understanding these individual fractions has guided development of targeted synthetic analogs including Davunetide (NAP) which was derived from the ADNP-related neuroprotective activity associated with VIP-stimulated neuroprotection.
Mechanism of Action
Individual fractions within Cerebrolysin activate different neurotrophic factor receptors: BDNF-like peptides activate TrkB; NGF-like peptides activate TrkA (p75NTR); GDNF-mimetics activate RET/GFRα receptor complex; CNTF-mimetics activate the tripartite CNTFR/LIFR/gp130 complex. The combination of simultaneous activity at multiple neurotrophic signaling nodes produces synergistic neuroprotective effects exceeding what any single neurotrophic factor can achieve.
Potential Benefits
- Simultaneous activation of multiple neurotrophic factor pathways
- Synergistic neuroprotection exceeding single-factor approaches
- BBB-penetrant delivery of neurotrophic activity
- Guides development of next-generation targeted neuropeptides
Research Dosage Notes
The following reflects doses used in published research studies. This is not medical advice.
Delivered as part of Cerebrolysin preparation clinically.
Amino Acid Sequence
Complex mixture of <10 kDa peptides; individual fractions being characterized
Side Effects & Safety
- As Cerebrolysin: see parent compound
Synergistic Compounds
The following compounds have been studied alongside Cerebrolysin Peptide Fraction for potential complementary or synergistic effects:
Learn More
References & Further Reading
- [object Object]